Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate

被引:67
作者
Johnson, JL
Cusack, B
Davies, MP
Fauq, A
Rosenberry, TL
机构
[1] Mayo Clin Jacksonville, Dept Pharmacol, Mayo Fdn Med Educ & Res, Jacksonville, FL 32224 USA
[2] Mayo Clin Jacksonville, Dept Neurosci, Mayo Fdn Med Educ & Res, Jacksonville, FL 32224 USA
关键词
D O I
10.1021/bi027065u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acetylcholinesterase (ACNE) contains a narrow and deep active site gorge with two sites of ligand binding, an acylation site (or A-site) at the base of the gorge, and a peripheral site (or P-site) near the gorge entrance. The P-site contributes to catalytic efficiency by transiently binding substrates on their way to the acylation site, where a short-lived acyl enzyme intermediate is produced. A conformational interaction between the A- and P-sites has recently been found to modulate ligand affinities. We now demonstrate that this interaction is of functional importance by showing that the acetylation rate constant of a substrate bound to the A-site is increased by a factor a when a second molecule of substrate binds to the P-site. This demonstration became feasible through the introduction of a new acetanilide substrate analogue of acetylcholine, 3-(acetamido)-N,N,N-trimethylanilinium (ATMA), for which a = 4. This substrate has a low acetylation rate constant and equilibrates with the catalytic site, allowing a tractable algebraic solution to the rate equation for substrate hydrolysis. ATMA affinities for the A- and P-sites deduced from the kinetic analysis were confirmed by fluorescence titration with thioflavin T as a reporter ligand. Values of a > 1 give rise to a hydrolysis profile called substrate activation, and the ACNE site-specific mutant W86F, and to a lesser extent wild-type human ACNE itself, showed substrate activation with acetylthiocholine as the substrate. Substrate activation was incorporated into a previous catalytic scheme for ACNE in which a bound P-site ligand can also block product dissociation from the A-site, and two additional features of the ACNE catalytic pathway were revealed. First, the ability of a bound P-site ligand to increase the substrate acetylation rate constant varied with the structure of the ligand: thioflavin T accelerated ATMA acetylation by a factor a(2) of 1.3, while propidium failed to accelerate. Second, catalytic rate constants in the initial intermediate formed during acylation (EAP, where EA is the acyl enzyme and P is the alcohol leaving group cleaved from the ester substrate) may be constrained such that the leaving group P must dissociate before hydrolytic deacylation can occur.
引用
收藏
页码:5438 / 5452
页数:15
相关论文
共 51 条
[1]   EFFECT OF REACTIVITY ON VIRTUAL TRANSITION-STATE STRUCTURE FOR THE ACYLATION STAGE OF ACETYLCHOLINESTERASE-CATALYZED HYDROLYSIS OF ARYL ESTERS AND ANILIDES [J].
ACHESON, SA ;
BARLOW, PN ;
LEE, GC ;
SWANSON, ML ;
QUINN, DM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (01) :246-252
[2]   ACETYLCHOLINESTERASE - 2 TYPES OF INHIBITION BY AN ORGANOPHOSPHORUS COMPOUND - ONE FORMATION OF PHOSPHORYLATED ENZYME AND OTHER ANALOGOUS TO INHIBITION BY SUBSTRATE [J].
ALDRIDGE, WN ;
REINER, E .
BIOCHEMICAL JOURNAL, 1969, 115 (02) :147-+
[3]   STEADY-STATE KINETIC-MODEL OF BUTYRYLCHOLINESTERASE FROM HORSE PLASMA [J].
AUGUSTINSSON, KB ;
BARTFAI, T ;
MANNERVIK, B .
BIOCHEMICAL JOURNAL, 1974, 141 (03) :825-834
[4]   Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine [J].
Bar-On, P ;
Millard, CB ;
Harel, M ;
Dvir, H ;
Enz, A ;
Sussman, JL ;
Silman, I .
BIOCHEMISTRY, 2002, 41 (11) :3555-3564
[5]   ACETYLCHOLINESTERASE-CATALYZED HYDROLYSIS OF ANILIDES - ACYLATION REACTION DYNAMICS AND INTRINSIC CHEMICAL TRANSITION-STATE STRUCTURES [J].
BARLOW, PN ;
ACHESON, SA ;
SWANSON, ML ;
QUINN, DM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (01) :253-257
[7]   Involvement of deacylation in activation of substrate hydrolysis by Drosophila acetylcholinesterase [J].
Brochier, L ;
Pontié, Y ;
Willson, M ;
Estrada-Mondaca, S ;
Czaplicki, J ;
Klaébé, A ;
Fournier, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18296-18302
[8]  
Camps P, 2000, MOL PHARMACOL, V57, P409
[9]   HORSE SERUM BUTYRYLCHOLINESTERASE KINETICS - A MOLECULAR MECHANISM BASED ON INHIBITION STUDIES WITH DANSYLAMINOETHYLTRIMETHYLAMMONIUM [J].
CAUET, G ;
FRIBOULET, A ;
THOMAS, D .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1987, 65 (06) :529-535
[10]  
CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369